Cathay Biotech (China) Investor Sentiment

688065 Stock   42.02  0.48  1.13%   
About 62% of Cathay Biotech's investor base is looking to short. The analysis of overall sentiment of trading Cathay Biotech stock suggests that many investors are alarmed at this time. The current market sentiment, together with Cathay Biotech's historical and current headlines, can help investors time the market. In addition, many technical investors use Cathay Biotech stock news signals to limit their universe of possible portfolio assets.
  
over a week ago at news.google.com         
Cathay General Bancorp Shares Purchased by Dean Investment Associates LLC - MarketBeat
Google News at Macroaxis
over three weeks ago at news.google.com         
Cathay Biotech Inc.s Stock Is Rallying But Financials Look Ambiguous Will The Momentum Continue - Si...
Google News at Macroaxis
over three weeks ago at news.google.com         
Foundry Partners LLC Invests 7.49 Million in Cathay General Bancorp - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
What Cathay Biotech Inc.s 38 percent Share Price Gain Is Not Telling You - Simply Wall St
Google News at Macroaxis
over two months ago at news.google.com         
Cathay Biotech Seems To Use Debt Quite Sensibly - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
Rhumbline Advisers Sells 1,391 Shares of Cathay General Bancorp - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Cathay Pacific Airways Shares Cross Below 200-Day Moving Average of 5.23 - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
CATHAY PAC AIR s A350 Fleet Returns to Service as Planned After Maintenance - AASTOCKS.com
Google News at Macroaxis
over three months ago at news.google.com         
Cathay Pacific cancels flights over Airbus A350 engine issue - Seeking Alpha
Google News at Macroaxis
over three months ago at news.google.com         
Bharat Biotech launches oral cholera vaccine after positive phase 3 trial - Business Standard
Google News at Macroaxis
over three months ago at news.google.com         
2 Biotech Stocks to Buy Hand Over Fist in August - AOL
Google News at Macroaxis
over three months ago at news.google.com         
UBS CATHAY PAC AIR Interim NP Beats by 15 Impact Expected to be Mildly Positive - AASTOCKS.com
Google News at Macroaxis
over three months ago at news.google.com         
Cathay Biotech Inc.s largest shareholders are private companies with 52 percent ownership, individua...
Google News at Macroaxis
over three months ago at news.google.com         
Cathay General Bancorp Shares Gap Down Following Weak Earnings - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
Cathay International Holdings Limited Stock Price Passes Above 50 Day Moving Average of 0.75 - Ameri...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Cathay Biotech that are available to investors today. That information is available publicly through Cathay media outlets and privately through word of mouth or via Cathay internal channels. However, regardless of the origin, that massive amount of Cathay data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Cathay Biotech news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cathay Biotech relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cathay Biotech's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cathay Biotech alpha.

Cathay Biotech Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
What Cathay Biotech Inc.s 38 percent Share Price Gain Is Not Telling You - Simply Wall St
10/22/2024
2
Cathay General Bancorp Shares Purchased by Dean Investment Associates LLC - MarketBeat
12/09/2024

Complementary Tools for Cathay Stock analysis

When running Cathay Biotech's price analysis, check to measure Cathay Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cathay Biotech is operating at the current time. Most of Cathay Biotech's value examination focuses on studying past and present price action to predict the probability of Cathay Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cathay Biotech's price. Additionally, you may evaluate how the addition of Cathay Biotech to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets